Cargando…
SAT-640 Glycemic Profile of Intravenous Glucocorticoid Induced Hyperglycemia Using Continuous Glucose Monitoring
Background: Intravenous (IV) steroids are widely used in critically ill patients and with chemotherapy. It is well known that glucocorticoid-induced hyperglycemia (GCIH) occurs within 3 hours following oral administration of steroids with typical postprandial glycemic excursions lasting 24-36 hours....
Autores principales: | Zhang, Fan, Goldberg, Zoe, Karam, Jocelyne Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207663/ http://dx.doi.org/10.1210/jendso/bvaa046.1010 |
Ejemplares similares
-
SAT-645 An Indication for Continuous Glucose Monitoring in Glucocorticoid-Treated Patients with Diabetes Mellitus
por: Sandhu, Harjyot, et al.
Publicado: (2020) -
Hemi Chorea and Hemi Balllismus: A Rare Presentation of Prolonged Uncontrolled Hyperglycemia
por: Karam, Jocelyne Georges, et al.
Publicado: (2021) -
SAT-128 Evaluating the Accuracy of Glycemic Markers and Risk of Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease by Continuous Glucose Monitoring
por: Presswala, Lubaina, et al.
Publicado: (2019) -
SAT-124 Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (HAPO FUS): Newborn Anthropometrics and Childhood Glucose Metabolism
por: Bianco, Monica, et al.
Publicado: (2019) -
SAT-127 Hypoglycemic Episodes in Type 2 Diabetes Mellitus : Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose
por: Aung, Tin, et al.
Publicado: (2019)